Literature DB >> 32926246

Positive association of a Sirt1 variant and parameters of oxidative stress on Alzheimer's disease.

Daniela Camporez1,2, Luciano Belcavello3, Jucimara Ferreira Figueiredo Almeida4,5, Geralda Gillian Silva-Sena6, Lúcia Helena Sagrillo Pimassoni7, Renato Lírio Morelato7,8, Maria do Carmo Pimentel Batitucci2,9, Flavia de Paula1,2.   

Abstract

Alzheimer's disease (AD) is a complex neurodegenerative disorder and the most common type of dementia in the elderly. Although its cause is not completely known, several studies suggest that oxidative stress plays an important role in the etiology of this disease. The SIRT1 and SOD2 proteins are linked to pathways that may impair oxidative stress. In this study, we analyzed the association between polymorphisms in these genes and in the APOE gene, through RT-PCR, as well as between environmental factors and the risk of AD. Additionally, the thiobarbituric acid reactive substance assay was performed to estimate the plasma level of malondialdehyde (MDA), a biomarker of lipid peroxidation. Furthermore, some cytogenetic studies indicate that cells of AD patients show increased chromosomal damage; thus, we performed the micronucleus cytome assay to assess cytogenetic damage in AD patients. As expected, the APOE polymorphisms were found to be highly associated with AD. Additionally, the CT genotype of the SIRT1 gene showed a positive association with the disease. The frequencies of genomic damage (micronucleus, buds, nucleoplasmic bridges and binucleated cells), the presence of cell death biomarkers (condensed chromatin, karyorrhexis and pyknosis), and the plasma level of MDA were significantly greater in AD patients than in controls. Our results support the hypothesis that AD is a condition with increased oxidative stress and genomic instability, which may contribute to the neurodegeneration in AD.

Entities:  

Keywords:  APOE; Genomic instability; Malondialdehyde; Oxidative stress; SIRT1; SOD2

Mesh:

Substances:

Year:  2020        PMID: 32926246     DOI: 10.1007/s10072-020-04704-y

Source DB:  PubMed          Journal:  Neurol Sci        ISSN: 1590-1874            Impact factor:   3.307


  19 in total

1.  A polymorphism in SOD2 is associated with development of Alzheimer's disease.

Authors:  H W Wiener; R T Perry; Z Chen; L E Harrell; R C P Go
Journal:  Genes Brain Behav       Date:  2007-03-21       Impact factor: 3.449

2.  The Clinical Dementia Rating (CDR): current version and scoring rules.

Authors:  J C Morris
Journal:  Neurology       Date:  1993-11       Impact factor: 9.910

3.  Microsomal lipid peroxidation.

Authors:  J A Buege; S D Aust
Journal:  Methods Enzymol       Date:  1978       Impact factor: 1.600

4.  Solutions to the kinetic problem in the micronucleus assay.

Authors:  M Fenech; A Morley
Journal:  Cytobios       Date:  1985

Review 5.  Oxidative stress and mitochondrial dysfunction-linked neurodegenerative disorders.

Authors:  Md Torequl Islam
Journal:  Neurol Res       Date:  2016-11-03       Impact factor: 2.448

6.  Clinical diagnosis of Alzheimer's disease: report of the NINCDS-ADRDA Work Group under the auspices of Department of Health and Human Services Task Force on Alzheimer's Disease.

Authors:  G McKhann; D Drachman; M Folstein; R Katzman; D Price; E M Stadlan
Journal:  Neurology       Date:  1984-07       Impact factor: 9.910

Review 7.  Amyloid-independent mechanisms in Alzheimer's disease pathogenesis.

Authors:  Sanjay W Pimplikar; Ralph A Nixon; Nikolaos K Robakis; Jie Shen; Li-Huei Tsai
Journal:  J Neurosci       Date:  2010-11-10       Impact factor: 6.167

8.  SIRT1, miR-132 and miR-212 link human longevity to Alzheimer's Disease.

Authors:  A Hadar; E Milanesi; M Walczak; M Puzianowska-Kuźnicka; J Kuźnicki; A Squassina; P Niola; C Chillotti; J Attems; I Gozes; D Gurwitz
Journal:  Sci Rep       Date:  2018-05-31       Impact factor: 4.379

9.  Sundown syndrome in patients with Alzheimer's disease dementia.

Authors:  Cristiani Sartorio Menegardo; Fernanda Alencar Friggi; Julia Baldon Scardini; Tais Souza Rossi; Thais Dos Santos Vieira; Alessandra Tieppo; Renato Lirio Morelato
Journal:  Dement Neuropsychol       Date:  2019 Oct-Dec

Review 10.  Apolipoprotein E, Receptors, and Modulation of Alzheimer's Disease.

Authors:  Na Zhao; Chia-Chen Liu; Wenhui Qiao; Guojun Bu
Journal:  Biol Psychiatry       Date:  2017-03-14       Impact factor: 12.810

View more
  3 in total

1.  A quantitative meta-analysis of vitamin C in the pathophysiology of Alzheimer's disease.

Authors:  Maryam Hamid; Sumaiya Mansoor; Sanila Amber; Saadia Zahid
Journal:  Front Aging Neurosci       Date:  2022-09-07       Impact factor: 5.702

2.  Severe COVID-19 in Alzheimer's disease: APOE4's fault again?

Authors:  Nian Xiong; Martin R Schiller; Jingwen Li; Xiaowu Chen; Zhicheng Lin
Journal:  Alzheimers Res Ther       Date:  2021-06-12       Impact factor: 6.982

Review 3.  Alzheimer Disease: Recent Updates on Apolipoprotein E and Gut Microbiome Mediation of Oxidative Stress, and Prospective Interventional Agents.

Authors:  Benson Oa Botchway; Favour C Okoye; Yili Chen; William E Arthur; Marong Fang
Journal:  Aging Dis       Date:  2022-02-01       Impact factor: 6.745

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.